Stocklytics Platform
Asset logo for symbol SLN
Silence Therapeutics plc
SLN59
$3.20arrow_drop_up1.91%$0.06
Penny Stock
Asset logo for symbol SLN
SLN59

$3.20

arrow_drop_up1.91%

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•
•

Silence Therapeutics plc (SLN) Stocklytics Forecast

As an AI, I can provide a forecast for Silence Therapeutics plc (SLN) stock price. However, please note that my predictions are based on historical data and algorithmic analysis, and they should not be taken as financial advice. Please conduct your own research and consult with a financial advisor before making any investment decisions. That being said, let's discuss the potential forecast for SLN stock.
Silence Therapeutics plc is a biotechnology company that focuses on developing and delivering targeted RNA-based therapeutics for the treatment of serious diseases. The company's proprietary platform, known as RNA interference (RNAi), has shown promising results in preclinical and early clinical trials. As a result, the company has attracted significant attention from investors and analysts.
add Silence Therapeutics plc to watchlist

Keep an eye on Silence Therapeutics plc

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

search
help

What is the analyst price prediction for Silence Therapeutics plc (SLN) stock?

Analysts have set a target price of $54.07 for Silence Therapeutics plc (SLN), based on forecasts from 29 analysts. The predicted price range extends from a high of $95 to a low of $18. This represents a potential increase of up to 2.87K% and a decrease of 462.5% from the current price of $3.2. These forecasts are as of 2022 Mar 22.
help

What are the analyst ratings for Silence Therapeutics plc (SLN) stock?

The analyst ratings for Silence Therapeutics plc (SLN) are distributed as follows: 6 analysts recommend buying, 0 have a neutral stance, and 1 suggest selling. The prevailing sentiment among the total of 7 analysts leans towards a buy rating. These ratings indicate the general sentiment among the analysts covering Silence Therapeutics plc.
help

What is the AI price prediction for Silence Therapeutics plc (SLN) stock?

At present, there is no AI or machine-learning-based price prediction available for Silence Therapeutics plc (SLN) stock. The lack of a forecast could stem from various factors, such as inadequate data or the necessity for model recalibration.

Take Your Investments to a Whole New Level